OakChart

Grifols SA ADR

GRFSHealthcare·Drug Manufacturers - General·Spain·Mid·NASD·Nov 13 • 4:40 AM ET

8.81+0.01 (0.09%)
2026-11-13 13:47 CET
Market cap
$2.27B
Revenue, TTM
8,821.37 USD m
Net income, TTM
565.20 USD m
Free cash flow, TTM
977.56 USD m
EPS diluted, TTM
0.83
Price / earnings
10.61
Compare

Price

GRFS against its 20, 50 and 200-day averages
Terms2050200BeatMiss
Patternshover a marker to name it
RS 18R 0.30Price0.290.337.007.508.008.509.002.0M4.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26GRFSclose 8.8120-day 8.2250-day 7.75200-day 7.988.8152w low 6.9652-week range, not 6 months

9.8% under the 52-week high of 9.77 on 18 Feb 2026. 52-week low 6.96 on 1 Jul 2026. Last 15 sessions, 14.6% high to low

Volume 0.00× normal · the line is the 50-bar volume average

Setup. RS line 18
CANSLIM 4 of 6 — fails: EPS Growth This Year: High (>25%); Performance: Year +50%
VCP 4 of 6 — fails: 50-Day Simple Moving Average: SMA50 above SMA200; RSI (14): Not Overbought (<60)
Minervini 2 of 4 — fails: 50-Day Simple Moving Average: SMA50 above SMA200; Performance: Year +50%
Zanger 3 of 5 — fails: Performance: Week +10%; Relative Volume: Over 1.5
Leaders 4 of 5 — fails: Performance: Year +50%
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 1 of 4 — fails: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 2 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1)
Value 2 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 1 of 4 — fails: Dividend Yield: Over 2%; Dividend Growth: Growing 2+ Years; Payout Ratio: Low (<20%)
Small Cap 2 of 4 — fails: Float: Under 100M; Performance: Year +50%
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 2 of 3 — fails: Performance: Year +100%

Profile

GRFS
52-week range, 66% of the way up
6.969.77

Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by Jose Antonio Grifols i Roig in 1909 and is headquartered in Barcelona, Spain.

Employees25258
IPOJun 02, 2011
Beta0.72
ATR, 14d0.23
Rel volume0.00
Short float2.32%
Insider own0.06%
Inst own56.33%

Snapshot

6 groups

Valuation

Index-
Market Cap$2.27B
Enterprise Value15.01B
Income565.20M
Sales8.82B
Book / share9.66
Cash / share2.14
Dividend Est.0.26 (2.96%)
Dividend TTM0.11 (1.20%)
Dividend Ex-DateDec 03, 2026
Dividend Gr. 3/5Y- -8.05%
Payout34.22%
Employees25258
IPOJun 02, 2011

Ratios

Price / earnings10.61
Forward price / earnings7.35
Price / earnings / growth0.33
Price / sales0.26
Price / book0.91
Price / cash4.12
Price / free cash flow2.33
Value / cash profit7.60
Value / sales1.70
Quick Ratio0.82
Current Ratio2.33
Debt / equity1.60
Long-term debt / equity1.50
Options and shortYes / Yes

Earnings

Earnings / share0.83
Earnings next year1.20
Earnings next quarter-
Earnings this year14.50%
Earnings next year22.76%
Earnings growth, 5 years22.10%
Past earnings growth27.36% -8.34%
Past sales growth10.04% 6.88%
Earnings vs last year35.26%
Sales vs last year6.15%
Earnings vs last quarter25.47%
Sales vs last quarter7.67%
EarningsNov 02 AMC
Surprise0.00% 3.48%

Ownership

Insiders own0.06%
Insider trades0.00%
Institutions own56.33%
Institution trades3.96%
Return on assets2.44%
Return on equity8.93%
Return on capital3.44%
Gross Margin37.09%
Operating margin16.40%
Profit Margin6.41%
20-day average7.13%
50-day average13.69%
200-day average10.42%

Technical

Shares out258.22M
Shares floating258.07M
Short / float2.32%
Short ratio9.80
Short interest5.98M
52-week high9.77 -9.8%
52-week low6.96 +26.6%
Volatility3.13% 2.88%
Average range0.23
Strength index73.40
Market sensitivity0.72
Relative volume0.00
Avg Volume610.38K
Volume12

Performance

Perf Week4.49%
Perf Month16.82%
Perf Quarter13.36%
Perf Half Y14.99%
Perf YTD-5.79%
Perf Year1.24%
Perf 3Y-0.92%
Perf 5Y-26.48%
Perf 10Y-44.04%
Recommendation2.60
Target Price11.30
Prev Close8.80
Price8.81
Change %0.09%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Feb 12, 2025ResumedMorgan StanleyOverweight
Mar 12, 2024DowngradeDeutsche BankHold → Sell
Apr 12, 2023UpgradeMorgan StanleyEqual-Weight → Overweight
Mar 03, 2023DowngradeMorgan StanleyOverweight → Equal-Weight
Feb 16, 2023UpgradeBarclaysUnderweight → Equal Weight
Jan 18, 2023UpgradeJefferiesHold → Buy
Apr 08, 2022InitiatedMorgan StanleyEqual-Weight
Nov 05, 2021DowngradeDeutsche BankBuy → Hold
Oct 19, 2021DowngradeBarclaysOverweight → Underweight
Oct 06, 2021UpgradeCitigroupNeutral → Buy

Peers

Mkt cap
TickerCompanyMkt cap
ADMAAdma Biologics Inc2.97B
TAKTakeda Pharmaceutical Co ADR69.02B
HAEHaemonetics Corp5.59B
KMDAKamada Ltd474.59M
ARGXArgen X SE ADR61.91B
QDELQuidelOrtho Corp728.67M
SNYSanofi ADR115.57B
GSKGSK Plc ADR101.01B
CERSCerus Corp397.85M
IMVTImmunovant Inc7.20B

Held by

AUM
TickerCompanyAUM
IBBiShares Biotechnology ETFAUM: 11.39B
BINVBrandes International ETFAUM: 576.24M
KOMPState Street SPDR S&P Kensho New Economies Composite ETFAUM: 2.54B
BSMCBrandes U.S. Small-Mid Cap Value ETFAUM: 175.57M
SPDWState Street SPDR Portfolio Developed World ex-US ETFAUM: 41.93B
CGICCapital Group International Core Equity ETFAUM: 2.59B
APIEActivePassive International Equity ETFAUM: 1.14B
QQQSInvesco NASDAQ Future Gen 200 ETFAUM: 20.78M
IBBQInvesco Nasdaq Biotechnology ETFAUM: 130.85M
AVNCAvantis All International Core Equity ETFAUM: 99.25M

News

latest 14 of 200

Quarterly earnings

2026Q3 EPS 0.320 matched 0.320, from 0.211 a year earlier. Sales 2,289 beat 2,212, from 2,141 a year earlier
EPS
0.32002024Q4 EPS 0.237 against 0.23224Q42025Q1 EPS 0.133 against 0.14925Q12025Q2 EPS 0.223 against 0.22625Q22025Q3 EPS 0.211 against 0.24225Q32025Q4 EPS 0.289 against 0.29625Q42026Q1 EPS 0.173 against 0.16126Q12026Q2 EPS 0.251 against 0.26426Q22026Q3 EPS 0.320 against 0.32026Q3
Sales, USD millions
2,34502024Q4 sales 2,058 against 2,03424Q42025Q1 sales 1,993 against 1,96125Q12025Q2 sales 2,179 against 2,19825Q22025Q3 sales 2,141 against 2,15325Q32025Q4 sales 2,340 against 2,34525Q42026Q1 sales 2,002 against 2,03126Q12026Q2 sales 2,133 against 2,16626Q22026Q3 sales 2,289 against 2,21226Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-11-02 16:300.3200.3200.2742,2892,212EPS 0.0% · sales +3.5%vs 2025Q3, year-ago quarter · EPS +51.9% · sales +6.9%2 EPS · 6 salesOpen +0.59% vs SPY +0.08%. Close +0.59% vs SPY +0.30%
2026Q2ended 2026-06-302026-07-28 16:300.2510.2640.2632,1332,166EPS -4.9% · sales -1.5%vs 2025Q2, year-ago quarter · EPS +12.6% · sales -2.1%2 EPS · 7 salesOpen +3.38% vs SPY -0.12%. Close +1.87% vs SPY -1.54%
2026Q1ended 2026-03-312026-05-07 16:300.1730.1610.1262,0022,031EPS +7.3% · sales -1.4%vs 2025Q1, year-ago quarter · EPS +29.8% · sales +0.4%2 EPS · 7 salesOpen +1.24% vs SPY +0.46%. Close +0.50% vs SPY +0.83%
2025Q4ended 2025-12-312026-02-26 16:300.2890.2960.1682,3402,345EPS -2.4% · sales -0.2%vs 2024Q4, year-ago quarter · EPS +22.0% · sales +13.7%2 EPS · 8 salesOpen -2.90% vs SPY -0.90%. Close +1.56% vs SPY -0.48%
2025Q3ended 2025-09-302025-11-04 16:300.2110.2420.2182,1412,153EPS -12.8% · sales -0.6%vs 2024Q3, year-ago quarter · EPS +21.8% · sales +10.4%2 EPS · 7 salesOpen -3.69% vs SPY -0.04%. Close -6.40% vs SPY +0.35%
2025Q2ended 2025-06-302025-07-29 16:300.2230.2260.1952,1792,198EPS -1.2% · sales -0.8%vs 2024Q2, year-ago quarter · EPS +156.9% · sales +10.8%2 EPS · 6 salesOpen +2.52% vs SPY +0.10%. Close +3.33% vs SPY -0.13%
2025Q1ended 2025-03-312025-05-12 16:300.1330.1490.0921,9931,961EPS -10.4% · sales +1.7%vs 2024Q1, year-ago quarter · EPS +56.9% · sales +12.9%2 EPS · 6 salesOpen +1.03% vs SPY +0.07%. Close +1.68% vs SPY +0.66%
2024Q4ended 2024-12-312025-02-26 16:300.2370.2320.1082,0582,034EPS +2.2% · sales +1.1%-3 EPS · 9 salesOpen -0.13% vs SPY +0.39%. Close +4.28% vs SPY -1.60%
2024Q3ended 2024-09-302024-11-07 16:300.1730.2160.0841,9391,912EPS -19.9% · sales +1.4%vs 2023Q3, year-ago quarter · EPS +15.1% · sales +22.7%3 EPS · 8 salesOpen +4.84% vs SPY +0.09%. Close -0.11% vs SPY +0.43%
2024Q2ended 2024-06-302024-07-30 16:300.0870.1460.0241,9671,947EPS -40.6% · sales +1.1%vs 2023Q2, year-ago quarter · EPS -47.4% · sales +7.6%4 EPS · 7 salesOpen +1.94% vs SPY +1.29%. Close -3.61% vs SPY +1.63%
2024Q1ended 2024-03-312024-05-14 16:300.0850.1060.0341,7651,749EPS -19.5% · sales +1.0%vs 2023Q1, year-ago quarter · EPS +94.1% · sales +4.4%3 EPS · 6 salesOpen +1.47% vs SPY +0.48%. Close +2.95% vs SPY +1.24%
2023Q3ended 2023-09-302023-11-02 08:300.1500.2040.0961,5801,683EPS -26.2% · sales -6.1%-3 EPS · 8 salesOpen +7.29% vs SPY +0.93%. Close +11.74% vs SPY +1.92%
2023Q2ended 2023-06-302023-07-27 08:300.1650.1990.0841,8281,855EPS -17.2% · sales -1.4%-3 EPS · 5 sales-
2023Q1ended 2023-03-312023-05-09 08:300.044--0.0171,690-EPS - · sales --2 EPS · 3 sales-
2022S1ended 2022-06-302022-07-27 16:300.2130.2930.2142,8542,803EPS -27.2% · sales +1.8%-1 EPS · 2 sales-
2026Q4ended 2026-12-31--0.331--2,313EPS - · sales -vs 2025Q4, year-ago quarter · EPS - · sales -1-

Annual earnings

2025FY EPS 0.818 missed 0.850, from 0.732 a year earlier. Sales 8,884 beat 8,816, from 7,510 a year earlier
EPS
1.30102018FY EPS 1.130 against 1.13520182019FY EPS 1.149 against 1.11820192020FY EPS 1.301 against 1.22220202021FY EPS 0.495 against 0.80420212022FY EPS 0.559 against 0.51120222023FY EPS 0.371 against 0.45220232024FY EPS 0.732 against 0.61120242025FY EPS 0.818 against 0.8502025
Sales, USD millions
8,88402018FY sales 5,109 against 5,06320182019FY sales 5,601 against 5,57320192020FY sales 6,482 against 6,49220202021FY sales 5,541 against 5,83120212022FY sales 6,431 against 6,33120222023FY sales 7,134 against 7,16820232024FY sales 7,510 against 7,48820242025FY sales 8,884 against 8,8162025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2030FYestimate-1.878--10,7314.69
2029FYestimate-1.682--10,3345.24
2028FYestimate-1.552--9,6695.68
2027FYestimate-1.199--9,1627.35
2026FYestimate-0.976--8,6149.02
2025FY0.8180.8500.6898,8848,81611.43
2024FY0.7320.6110.2507,5107,48810.17
2023FY0.3710.4520.0677,1347,16831.13
2022FY0.5590.5110.3236,4316,33115.20
2021FY0.4950.8040.3295,5415,83122.68
2020FY1.3011.2221.0306,4826,49214.18
2019FY1.1491.1181.0215,6015,57320.28
2018FY1.1301.1351.0285,1095,06316.25
2017FY1.1871.1721.1055,2855,22619.31
2016FY0.9350.9180.8834,4014,32717.19
2015FY0.9550.9520.8654,2744,1909.23
2014FY0.9450.9800.8184,0604,0539.32
2013FY0.8660.8330.7163,7783,78110.17
2012FY0.6050.5990.5203,4553,42814.56
2011FY0.3160.3500.1532,3312,35327.91
2010FY0.3420.3990.3371,3291,35425.76

Quarterly results

2026Q3 revenue 2,347, from 2,180 a year earlier. Operating margin 19.3%, from 18.9% a year earlier
Revenue, USD millions
2,34702024Q4 revenue 2,10824Q42025Q1 revenue 1,88025Q12025Q2 revenue 2,14425Q22025Q3 revenue 2,18025Q32025Q4 revenue 2,30725Q42026Q1 revenue 1,98926Q12026Q2 revenue 2,17926Q22026Q3 revenue 2,34726Q3
Operating margin
19.302024Q4 operating margin 19.3%24Q42025Q1 operating margin 15.3%25Q12025Q2 operating margin 18.5%25Q22025Q3 operating margin 18.9%25Q32025Q4 operating margin 13.9%25Q42026Q1 operating margin 14.6%26Q12026Q2 operating margin 17.6%26Q22026Q3 operating margin 19.3%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E 0.98 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-110.98-0.7%
2026FYSUSD millions2026-11-118,614-0.2%
2026FYRper share2026-11-100.93-0.1%
2026Q4Eper share2026-11-030.33-14.3%
2026Q4Rper share2026-11-030.30-14.4%
2026Q4SUSD millions2026-11-032,313-4.4%
2026Q3Eper share2026-07-290.29-2.9%
2026Q3Rper share2026-07-290.26+0.9%
2026Q3SUSD millions2026-07-292,248-3.1%
2026Q2Eper share2026-05-080.28+0.9%
2026Q2Rper share2026-05-080.24+0.8%
2026Q2SUSD millions2026-05-082,2960.0%
2025FYEper share2026-02-180.850.0%
2025FYSUSD millions2026-02-188,8160.0%
2025FYRper share2026-02-160.74+0.3%
2025Q4Eper share2025-11-050.29-19.1%
2025Q4Rper share2025-11-050.27-19.5%
2025Q4SUSD millions2025-11-052,233-3.9%
2025Q3Eper share2025-07-300.27+18.2%
2025Q3Rper share2025-07-300.23+15.8%
2025Q3SUSD millions2025-07-302,140+0.4%
2025Q2Eper share2025-05-130.22+9.1%
2025Q2Rper share2025-05-130.19+13.9%
2025Q2SUSD millions2025-05-132,147+7.9%
2025Q1Eper share2025-02-280.16-
2025Q1Rper share2025-02-280.13-
2025Q1SUSD millions2025-02-281,785-
2024FYEper share2025-02-270.55+0.1%
2024FYRper share2025-02-270.35-1.5%
2024FYSUSD millions2025-02-277,488+0.0%
2024Q3Eper share2024-07-310.25+2.3%
2024Q3Rper share2024-07-310.21+1.9%
2024Q3SUSD millions2024-07-311,887-0.2%
2023FYEper share2024-02-280.450.0%
2023FYSUSD millions2024-02-287,1680.0%
2023Q4Eper share2024-02-270.220.0%
2023Q4Rper share2024-02-270.160.0%
2023Q4SUSD millions2024-02-271,9140.0%
2023FYRper share2024-02-260.250.0%
2023Q3SUSD millions2023-10-301,683+0.3%
2023Q3Eper share2023-10-130.20-0.4%
2023Q3Rper share2023-10-130.11-0.9%

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share1.1051.0281.0211.030.3290.3230.0670.250.6670.8305-
Sales USD millions4,9215,2935,7076,0885,8316,3737,1277,8028,4918,821-
Shares million shares261258258258256256257258258-258
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share0.0840.1080.0920.1950.2180.1680.1260.2630.274
Sales USD millions1,9702,1081,8792,1442,1802,3071,9892,1792,347
Shares million shares257258258257257258258258258

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Total Revenue8,821.378,491.42+8.8%7,801.57+9.5%7,126.69+11.8%6,373.07+9.3%5,830.85-4.2%6,087.51+6.7%5,706.70+7.8%5,293.21
Cost of Goods Sold Incl. D&A5,549.565,460.06+10.2%4,956.78+7.1%4,627.57+11.1%4,166.89+13.0%3,686.14+0.8%3,657.15+14.0%3,208.70+8.0%2,972.08
Gross Profit3,271.813,031.36+6.6%2,844.79+13.8%2,499.12+13.3%2,206.18+2.9%2,144.71-11.8%2,430.36-2.7%2,498.00+7.6%2,321.14
Selling, General and Administrative Excl. Other1,824.801,620.64+1.6%1,595.21-7.6%1,725.54+16.2%1,485.56+0.0%1,485.51+12.7%1,318.50+6.2%1,241.77+8.1%1,148.32
Research and Development464.54420.96+17.7%357.74+0.1%357.36+7.3%333.00-6.0%354.09+18.8%297.99+5.0%283.78+8.9%260.52
Other Operating Expense0.0015.80-52.6%33.30+23.2%27.020.000.000.000.000.00
Operating Income1,447.001,394.92+14.7%1,216.28+62.9%746.56+3.6%720.62+9.3%659.20-40.7%1,111.85-11.5%1,256.24+7.1%1,172.82
Interest Expense616.72705.36-8.8%773.15+19.8%645.30+23.7%521.83+58.8%328.58+15.5%284.58-25.9%383.86+10.9%345.99
Unusual Expense0.00-33.86-11.68-1.58-6.62-149.8%13.30-63.50-256.1%40.670.00
Net Income Before Taxes829.80703.10+59.6%440.46+182.5%155.90-42.8%272.48-19.0%336.52-63.0%909.32-4.2%948.75+9.1%869.33
Income Taxes150.99129.79-48.1%250.08+433.6%46.87-50.5%94.70-5.9%100.62-48.0%193.38+2.6%188.55+21.6%155.06
Consolidated Net Income670.36564.29+145.1%230.19+30.1%176.95-37.9%284.97-9.1%313.61-61.2%808.23+11.3%725.99+3.5%701.25
Net Income From Continuing Operations565.20453.69+167.3%169.74+271.0%45.75-79.1%218.90-1.9%223.07-68.4%705.13+0.8%699.69-0.6%703.89
Net Income565.20453.69+167.3%169.74+271.0%45.75-79.1%218.90-1.9%223.07-68.4%705.13+0.8%699.69-0.6%703.89
EPS (Recurring) per share0.830.63+162.5%0.24+242.9%0.07-78.1%0.32-5.9%0.34-64.9%0.97-8.5%1.06+2.9%1.03
EPS (Basic, Before Extraordinaries) per share0.830.67+168.0%0.25+257.1%0.07-78.1%0.32-3.0%0.33-68.0%1.03+1.0%1.02-1.0%1.03
EPS (Diluted) per share0.830.67+168.0%0.25+257.1%0.07-78.1%0.32-3.0%0.33-68.0%1.03+1.0%1.02-1.0%1.03
EBITDA1,973.661,902.78+12.6%1,689.95+37.5%1,229.19+7.0%1,149.27+6.0%1,084.44-26.6%1,478.39-7.3%1,594.76+10.6%1,442.52
Non-Operating Income (Expense)0.66-20.31-14.36-127.1%53.07-20.9%67.07+249.1%19.21+3.6%18.54-84.2%117.05+175.3%42.51
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Price To Earnings Ratio ratio statement ratio, not the snapshot10.6010.6029.671,651.4397.2534.3017.7422.8017.78
Price To Sales Ratio ratio0.560.750.651.100.901.312.072.802.37
Gross Margin %37.0935.7036.4635.0734.6236.7839.9243.7743.85
Operating Margin %16.4016.4315.5910.4811.3111.3118.2622.0122.16
Net Margin %6.415.342.180.643.433.8311.5812.2613.30
Shares Outstanding million shares258.22258.220.0%258.22+0.5%256.91+0.3%256.230.0%256.35-0.8%258.41+0.2%258.01+0.2%257.61
Market Capitalization2,272.372,272.37+18.6%1,915.38-35.4%2,964.90+35.9%2,182.16-24.2%2,878.86-39.6%4,765.08-20.7%6,008.94+27.1%4,726.76

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue2,347.06+7.7%2,178.92+1.7%1,988.88+5.8%2,306.52+9.4%2,179.96+10.7%2,143.51+9.5%1,879.50+6.5%2,107.58+10.8%
Cost of Goods Sold Incl. D&A1,418.59+7.3%1,360.37+2.0%1,263.52+10.0%1,507.08+16.8%1,322.54+12.9%1,333.14+3.4%1,148.39+6.4%1,289.97+11.1%
Gross Profit928.47+8.3%818.55+1.0%725.36-0.8%799.44-2.2%857.42+7.4%810.37+21.3%731.11+6.8%817.61+10.2%
Selling, General and Administrative Excl. Other475.16+6.4%436.02+5.3%434.04-2.0%479.58+16.9%446.43-0.2%414.18+4.4%442.77-5.0%410.12-18.3%
Research and Development100.10-11.7%99.99+6.7%105.29+4.2%159.15+29.7%113.38+17.4%93.69+26.7%101.08+3.0%122.67+0.5%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income453.30+10.3%382.53-3.4%291.31+1.0%319.86-21.5%410.99+17.1%396.19+45.8%288.34+32.0%407.49+69.9%
Interest Expense176.03-3.5%91.85-49.1%162.62+0.6%186.22+8.2%182.39-16.0%180.52-24.3%161.65-4.9%172.08+7.1%
Unusual Expense0.000.000.000.000.00-29.38-1859.3%0.000.00
Net Income Before Taxes276.12+20.5%290.68+34.1%128.69+1.6%134.30-43.0%229.10+71.2%216.71+910.3%126.69+160.9%235.41+185.5%
Income Taxes65.58+2.6%74.41+25.9%28.08+16.8%-17.08-112.6%63.93+55.4%59.08+30.0%24.04-10.6%135.21+354.8%
Consolidated Net Income208.24+24.2%212.78+35.7%102.95+5.8%146.39+63.8%167.61+86.1%156.85+488.3%97.27+302.3%89.37+6.9%
Net Income From Continuing Operations186.38+25.6%179.06+34.9%85.40+35.9%114.36+55.4%148.37+161.3%132.69+730.4%62.86+170.4%73.57+22.2%
Net Income186.38+25.6%179.06+34.9%85.40+35.9%114.36+55.4%148.37+161.3%132.69+730.4%62.86+170.4%73.57+22.2%
EPS (Recurring) per share0.27+22.7%0.26+62.5%0.13+44.4%0.17+54.5%0.22+175.0%0.16+433.3%0.09+200.0%0.11+22.2%
EPS (Basic, Before Extraordinaries) per share0.27+22.7%0.26+30.0%0.13+44.4%0.17+54.5%0.22+175.0%0.20+900.0%0.09+200.0%0.11+22.2%
EPS (Diluted) per share0.27+22.7%0.26+30.0%0.13+44.4%0.17+54.5%0.22+175.0%0.20+900.0%0.09+200.0%0.11+22.2%
EBITDA584.46+10.0%506.94+0.2%412.98+1.7%469.27-10.6%531.18+13.0%506.10+29.0%405.96+21.9%524.97+47.3%
Non-Operating Income (Expense)0.00-100.0%0.000.000.660.50-28.330.000.00-100.0%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Price To Earnings Ratio ratio statement ratio, not the snapshot10.6010.0111.9015.2320.7729.3928.3529.67
Price To Sales Ratio ratio0.560.560.630.750.810.760.610.65
Gross Margin %39.5637.5736.4734.6639.3337.8138.9038.79
Operating Margin %19.3117.5614.6513.8718.8518.4815.3419.33
Net Margin %7.948.224.294.966.816.193.343.49
Shares Outstanding million shares258.22+0.3%258.22+0.3%258.220.0%258.220.0%257.44+0.2%257.440.0%258.22+0.5%258.22+0.5%
Market Capitalization2,272.37-11.4%1,828.23-21.7%2,070.96+12.8%2,407.10+25.7%2,564.14+12.2%2,334.34+44.1%1,835.97+7.0%1,915.38-35.4%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/20182017FY12/31/2017
Cash & Short Term Investments968.92-4.5%1,014.56+73.4%585.00+0.0%584.83-21.5%745.43+5.1%709.23-74.3%2,759.91+133.5%1,181.78+11.0%1,064.53
Short Term Receivables992.41+10.7%896.73+0.1%895.72+11.2%805.58+43.0%563.46-8.7%616.91+16.8%528.13+15.0%459.06-0.8%462.63
Inventories3,870.99+5.0%3,686.48-4.2%3,846.83+12.6%3,416.65+33.0%2,569.34+4.9%2,449.89-6.8%2,629.56+18.0%2,228.41+13.9%1,956.46
Other Current Assets126.84-61.9%333.10-76.9%1,445.08+806.1%159.48-93.3%2,388.07+2376.0%96.45-4.9%101.45-9.9%112.63+112.0%53.12
Total Current Assets5,959.16+0.5%5,930.87-12.4%6,772.63+36.4%4,966.54-20.7%6,266.29+61.8%3,872.48-35.7%6,019.05+51.2%3,981.88+12.6%3,536.74
Net Property, Plant & Equipment4,758.87+6.6%4,463.16-3.6%4,631.09+4.1%4,448.82+17.0%3,801.83+3.5%3,674.08+14.3%3,214.17+44.0%2,231.41+5.6%2,113.47
Total Investments and Advances540.25-1.6%548.97+9.7%500.34-81.0%2,636.22+2.3%2,575.96+6.3%2,422.70+1399.0%161.62-38.2%261.58-23.3%341.12
Long-Term Note Receivable156.20+655.3%20.68-86.3%150.92+46.5%103.03+1.7%101.33+2.4%98.93-15.2%116.72+2.0%114.45-
Intangible Assets11,228.92+5.0%10,695.87+0.5%10,642.55+0.1%10,630.94+18.8%8,945.05+6.1%8,430.16+8.2%7,790.82+3.3%7,538.81+7.1%7,036.50
Deferred Tax Assets542.60+48.3%365.92+5.5%346.80+7.5%322.59+23.2%261.94+42.8%183.44+32.8%138.09+7.3%128.65+61.9%79.44
Other Assets18.79-87.6%151.76-4.9%159.63+1512.4%9.90+12.1%8.83+15.1%7.67+25.7%6.10-4.1%6.36+9.8%5.79
Total Assets23,204.78+4.6%22,177.25-4.4%23,203.97+0.4%23,118.04+5.3%21,961.22+17.5%18,689.45+7.1%17,446.58+22.3%14,263.14+8.8%13,113.05
Short Term Debt Incl. Current Port. of LT Debt453.34-16.0%539.54-43.9%961.54+32.2%727.09-73.3%2,722.66+596.3%391.01+9.0%358.69+20.2%298.50+86.8%159.79
Accounts Payable987.71+11.9%882.56-2.9%909.08+16.4%781.14+9.2%715.29-2.8%736.11+12.7%653.16+1.7%642.32+26.4%508.05
Income Tax Payable29.36-53.2%62.68+290.8%16.04-4.2%16.74+225.7%5.14+20.7%4.26-36.4%6.70+205.9%2.19-72.8%8.06
Other Current Liabilities900.80+20.4%747.90+9.6%682.14+21.3%562.41+10.7%507.90+1.1%502.23-2.6%515.41+4.3%494.30-0.8%498.47
Total Current Liabilities2,371.21+6.2%2,232.69-13.1%2,568.80+23.1%2,087.38-47.2%3,950.99+141.9%1,633.61+6.5%1,533.96+6.7%1,437.31+22.4%1,174.37
Long Term Debt9,816.05+9.2%8,988.41-11.7%10,184.35+5.2%9,678.73+22.8%7,880.94-2.3%8,065.43+5.9%7,617.38+10.7%6,882.34-2.5%7,058.52
Provision for Risks Charges139.76+7.9%129.49+0.3%129.16+10.0%117.46+328.2%27.43-17.8%33.37+270.4%9.01+28.9%6.99+1.0%6.92
Deferred Tax Liabilities1,065.23+0.5%1,059.74-4.3%1,107.13-10.7%1,240.32+53.2%809.47+18.8%681.29+30.9%520.65+12.6%462.29-1.0%467.01
Other Liabilities864.40+2.9%839.90-6.6%899.27-5.5%951.69-0.3%954.29+2825.5%32.62-52.3%68.43-25.4%91.74+223.3%28.38
Total Liabilities14,256.65+7.6%13,250.23-11.0%14,888.71+5.8%14,075.59+3.3%13,623.12+30.4%10,446.32+7.1%9,749.44+9.8%8,880.67+1.7%8,735.19
Non-Equity Reserves18.79+30.1%14.44-5.3%15.25-5.5%16.14-5.6%17.10-17.8%20.81+63.0%12.77-5.7%13.54-4.6%14.20
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity6,190.53+1.6%6,092.60+2.7%5,930.18-9.4%6,542.18+4.2%6,281.45+0.5%6,250.37+15.5%5,412.83+12.1%4,830.44+10.8%4,357.80
Total Shareholders Equity6,190.53+1.6%6,092.60+2.7%5,930.18-9.4%6,542.18+4.2%6,281.45+0.5%6,250.37+15.5%5,412.83+12.1%4,830.44+10.8%4,357.80
Accumulated Minority Interest2,738.82-2.9%2,819.98+19.0%2,369.83-4.6%2,484.14+21.8%2,039.56+3.4%1,971.95-13.2%2,271.55+321.8%538.48+9073.4%5.87
Total Equity8,929.34+0.2%8,912.57+7.4%8,300.00-8.0%9,026.31+8.5%8,321.00+1.2%8,222.32+7.0%7,684.37+43.1%5,368.92+23.0%4,363.67
Total Liabilities & Stockholders Equity23,204.78+4.6%22,177.25-4.4%23,203.97+0.4%23,118.04+5.3%21,961.22+17.5%18,689.45+7.1%17,446.58+22.3%14,263.14+8.8%13,113.05
Book Value Per Share per share9.10+1.7%8.95+2.5%8.73-65.8%25.53+175.7%9.26+1.4%9.13+15.4%7.91+12.0%7.06+12.6%6.27
Tangible Book Value Per Share per share-19.51-17.83-18.34-15.96-10.39-8.44-9.22-10.51-10.25
Full-Time Employees people25,258+6.0%23,833+0.4%23,744-9.8%26,326+13.3%23,245-1.8%23,668-1.4%24,016+13.1%21,243+16.0%18,309
Price to Book Ratio ratio0.910.841.210.871.102.022.942.603.69
Return on Assets %2.000.740.200.971.103.904.415.146.35
Return on Equity %7.392.710.733.413.5612.0913.6615.3218.24
Return on Invested Capital %2.831.130.281.351.584.935.376.016.62
Quick Ratio ratio0.881.011.140.740.940.872.211.221.35
Current Ratio ratio2.512.662.642.381.592.373.922.773.01

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Net Income807.93694.08+44.5%480.27+114.6%223.81-41.1%379.67-8.3%414.23-58.6%1,001.61+9.5%914.54+6.8%856.31
Depreciation524.11507.86+7.2%473.67-1.9%482.63+12.6%428.65+0.8%425.24+16.0%366.54+8.3%338.52+25.5%269.70
Other Funds (Non Cash)27.997.90-15.0%9.29-92.99-167.61-447.0%48.30-211.05-69.97-119.20
Funds from Operations1,360.041,209.84+25.6%963.23+57.0%613.46-4.3%640.72-27.8%887.77-23.3%1,157.10-2.2%1,183.09+17.5%1,006.81
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-70.52-28.21-323.2%12.64-377.03-640.87-168.62-240.2%120.23-541.31-133.22
Cash from Operating Activities1,289.521,181.62+21.1%975.87+312.8%236.43-0.16-100.0%719.14-43.7%1,277.33+99.0%641.78-26.5%873.59
Capital Expenditures-524.65-477.39-401.70-335.49-394.70-372.43-413.31-461.47-363.03
Net Assets From Acquisitions-51.41-121.89-309.23-31.86-1,611.42-613.60-534.18-134.04-618.28
Sale of Fixed Assets and Businesses4.534.51-82.3%25.42+1.2%25.13-74.7%99.48+300.0%24.87+7922.6%0.31-89.8%3.03+366.2%0.65
Purchase or Sale of Investments-58.91-58.69-47.43-84.51-173.05-48.43-31.05-21.770.00
Purchase of Investments-64.58-64.33-47.43-100.88-173.05-50.19-31.05-21.770.00
Sale Or Maturity of Investments5.665.640.00-100.0%16.360.00-100.0%1.760.000.00-
Other Uses5.270.000.000.000.000.000.000.00-24.46
Other Sources-0.00-100.0%1,692.040.000.000.000.000.00-100.0%82.72
Cash from Investing Activities-625.18-653.45-168.1%959.10-426.74-2,079.69-1,009.59-978.23-614.25-922.41
Cash Dividends Paid-99.41-144.46-1.040.00-0.62-306.07-129.08-267.21-328.96
Change in Capital Stock-150.05-145.590.000.00-3.64-148.580.000.000.00
Repurchase of Common Pref Stock-146.15-145.590.000.00-3.64-148.580.000.000.00
Sale of Common Pref Stock-3.900.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options-3.900.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net--214.43-1,404.45-553.5%309.67-76.81-102.3%3,343.91-277.44-8.41-119.1%44.14
Change in Long Term Debt-------0.000.00
Issuance of Long Term Debt-------0.000.00
Reduction of Long Term Debt-------0.000.00
Net Financing Active Other Cash Flow136.7441.76-25.9%56.38+3491.1%1.57-2.93-89.24-9.07-101.35-122.0%461.13
Other Financing Activities Uses94.820.000.000.00-2.93-92.39-10.52-101.350.00
Cash from Financing Activities-857.66-597.02-1,469.71-892.7%185.40-193.60-107.2%2,702.28-415.58-376.97-313.8%176.31
Exchange Rate Effect25.56-106.09-588.4%21.72-16.32-143.7%37.36-43.0%65.55-68.58-400.4%22.83-50.6%46.25
Net Change in Cash-166.60-174.93-135.9%486.98-21.22-2,236.09-190.3%2,477.39-185.06-326.61-288.0%173.74
Free Cash Flow977.56882.55+21.8%724.33-6.21-280.23-165.7%426.75-55.5%957.96+225.4%294.38-50.9%599.91
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow ratio5.678.627.00--63.1415.23587.1946.40
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments552.02-24.3%586.51-10.6%808.84-0.5%968.92-4.5%729.63+1.4%655.82-71.0%813.19+67.9%1,014.56+73.4%
Short Term Receivables1,225.58-4.9%1,168.45-2.5%1,103.81-1.7%992.41+10.7%1,288.42+14.6%1,198.66+19.6%1,122.63+4.2%896.73+0.1%
Inventories3,940.26+0.2%3,992.40+1.6%3,984.31+4.6%3,870.99+5.0%3,934.34+2.0%3,928.72+1.2%3,807.46-3.3%3,686.48-3.5%
Other Current Assets353.25+6.3%317.84-15.3%156.70-55.1%126.84-61.9%332.42+38.3%375.06+43.8%349.06-80.6%333.10-81.7%
Total Current Assets6,071.12-3.4%6,065.21-1.5%6,053.66-0.6%5,959.16+0.5%6,284.81+5.8%6,158.26-16.9%6,092.34-16.5%5,930.87-16.8%
Net Property, Plant & Equipment3,619.95-0.9%4,637.22-2.1%3,644.41+4.1%4,758.87+6.6%3,653.62+3.5%4,738.08+4.9%3,501.05-0.3%4,463.16-3.6%
Total Investments and Advances544.07-6.8%459.61-16.9%701.69+26.1%540.25-1.6%583.62-24.2%552.89-8.0%556.51-30.6%548.97-12.2%
Intangible Assets12,261.50-0.7%11,228.35-0.3%12,240.97+1.0%11,228.92+5.0%12,353.33+3.9%11,267.41+5.3%12,125.44+4.5%10,695.87+0.5%
Deferred Tax Assets-544.21+21.0%-542.60+48.3%-449.63+26.5%-365.92+3.9%
Other Assets537.26+18.7%20.58+67.3%493.14+27.9%18.79-87.6%452.79-10.5%12.30-92.0%385.70-22.5%151.76-11.0%
Total Assets23,036.17-1.3%22,968.90-1.0%23,133.87+2.1%23,204.78+4.6%23,328.18+3.1%23,203.68-2.9%22,661.04-4.4%22,177.25-6.4%
Short Term Debt Incl. Current Port. of LT Debt621.31-11.1%480.19-21.4%678.65-4.4%453.34-16.0%699.26-38.4%610.70-78.7%710.01-62.3%539.54-45.6%
Accounts Payable0.001,144.44+11.0%0.00987.71+11.9%0.001,031.44+9.6%0.00882.56-1.7%
Income Tax Payable-105.18+4.1%-29.36-53.2%-101.03+84.8%-62.68+290.8%
Other Current Liabilities1,985.47+8.3%826.61+39.4%1,768.63+8.2%900.80+20.4%1,832.69+22.7%592.97+9.0%1,634.26+17.0%747.90+14.7%
Total Current Liabilities2,606.78+3.0%2,556.42+9.4%2,447.27+4.4%2,371.21+6.2%2,531.95-3.7%2,336.14-47.0%2,344.27-28.6%2,232.69-12.7%
Long Term Debt9,873.94-7.6%9,257.30-6.4%10,461.98+3.1%9,816.05+9.2%10,684.05+8.3%9,890.24+15.9%10,142.94-2.7%8,988.41-11.7%
Provision for Risks Charges0.00138.34-3.4%0.00139.76+7.9%0.00143.26+5.2%0.00129.49+0.3%
Deferred Tax Liabilities-1,058.70-2.2%-1,065.23+0.5%-1,082.61+1.9%-1,059.74-4.3%
Other Liabilities1,192.64-4.1%816.32+0.3%1,183.31-2.6%864.40+2.9%1,243.32+1.6%813.57-3.7%1,214.76-1.5%839.90-6.6%
Total Liabilities13,673.36-5.4%13,827.07-3.1%14,092.56+2.9%14,256.65+7.6%14,459.32+5.4%14,265.81-4.8%13,701.98-8.3%13,250.23-10.9%
Non-Equity Reserves0.0018.29-2.6%0.0018.79+30.1%0.0018.78+26.3%0.0014.44-5.3%
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity6,574.30+8.0%6,340.74+4.5%6,288.71+3.2%6,190.53+1.6%6,085.26+1.9%6,067.72+1.2%6,091.74-5.1%6,092.60-5.4%
Total Shareholders Equity6,574.30+8.0%6,340.74+4.5%6,288.71+3.2%6,190.53+1.6%6,085.26+1.9%6,067.72+1.2%6,091.74-5.1%6,092.60-5.4%
Accumulated Minority Interest2,788.51+0.2%2,782.79-2.4%2,752.61-4.0%2,738.82-2.9%2,783.59-5.7%2,851.37-1.6%2,867.32+21.9%2,819.98+19.0%
Total Equity9,362.81+5.6%9,123.53+2.3%9,041.31+0.9%8,929.34+0.2%8,868.85-0.6%8,919.09+0.3%8,959.06+2.1%8,912.57+1.2%
Total Liabilities & Stockholders Equity23,036.17-1.3%22,968.90-1.0%23,133.87+2.1%23,204.78+4.6%23,328.18+3.1%23,203.68-2.9%22,661.04-4.4%22,177.25-6.4%
Book Value Per Share per share9.66+7.9%9.32+4.4%9.24+3.2%9.10+1.7%8.95+1.8%8.93+1.2%8.95-5.3%8.95-5.6%
Tangible Book Value Per Share per share-22.02-18.93-23.05-19.51-24.35-20.20-23.37-17.83
Full-Time Employees people---25,258+6.0%---23,833+0.4%
Price to Book Ratio ratio0.910.770.881.041.121.010.790.84
Return on Assets %2.442.282.102.021.821.380.900.74
Return on Equity %8.938.507.777.466.935.403.342.71
Return on Invested Capital %1.131.150.510.710.880.830.390.49
Quick Ratio ratio0.820.810.850.880.930.950.971.01
Current Ratio ratio2.332.372.472.512.482.642.602.66

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income33.71-77.6%334.36+158.7%85.40+36.0%354.47-8.7%150.21129.25+29.1%62.81+169.6%388.35+64.2%
Depreciation130.01+4.2%125.04+4.1%121.67+3.5%147.38+21.1%124.74+5.8%120.16-1.9%117.52+2.3%121.73+9.1%
Other Funds (Non Cash)260.62+71.3%-77.2046.80-51.7%-202.23152.13-28.4%-38.8096.83+88.2%-174.60
Funds from Operations424.34-0.6%382.20+81.5%253.87-8.4%299.62-10.7%427.08+41.3%210.61+47.6%277.17+46.1%335.48+198.2%
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-20.74-116.85-125.18192.26-15.4%-48.66-305.2%-37.22-128.4%-134.70227.22+317.5%
Cash from Operating Activities403.60+6.7%265.35+53.0%128.69-9.7%491.88-12.6%378.43+16.1%173.38-36.6%142.47562.70+237.1%
Capital Expenditures-126.54-139.08-105.29-153.74-127.46-105.84-92.18-156.74
Net Assets From Acquisitions-14.95-7.00-22.23-7.23-4.13-102.7%-8.99-102.01-311.44-1561.5%
Sale of Fixed Assets and Businesses-3.51-103.2%3.510.004.53111.00-111.00-106.5%0.00-1,395.40-24075.9%
Purchase or Sale of Investments24.55-24.550.00-58.910.00-100.0%0.000.00-47.77
Purchase of Investments24.55-24.550.00-64.580.00-100.0%0.000.00-47.77
Sale Or Maturity of Investments0.000.000.005.660.000.000.000.00-100.0%
Other Uses-36.0510.53-10.5341.31+121.7%-18.99-8.97-207.4%-13.3518.63+16.4%
Other Sources0.00--0.00-100.0%0.00--1,704.14
Cash from Investing Activities-156.49-156.60-138.05-174.03-150.58-123.80-108.5%-207.54-188.57
Cash Dividends Paid-69.760.000.00-29.65-115.370.000.00-1.05
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock0.00-100.0%0.000.00-150.053.900.000.000.00
Repurchase of Common Pref Stock0.000.000.00-146.150.000.000.000.00
Sale of Common Pref Stock0.00-100.0%0.000.00-3.903.900.000.000.00
Proceedsfrom Stock Options0.00-100.0%0.000.00-3.903.900.000.000.00
Issuance or Reduction of Debt, Net-274.39-282.88-136.8884.03+40.3%-56.21-81.46-163.7%-161.62-196.6%59.91-62.3%
Net Financing Active Other Cash Flow-5.8115.21-15.21-172.3%142.55+450.2%-1.43-105.8%-120.2621.05+65.0%25.91+1077.7%
Other Financing Activities Uses-5.81-349.4%15.21-15.21100.632.33-102.970.000.00
Cash from Financing Activities-279.82-337.83-152.09-87.93-169.10-201.72-413.4%-140.56-178.1%-36.69-176.7%
Exchange Rate Effect1.028.1717.55-1.19-104.3%-5.61-66.64-2144.2%-33.06-575.7%27.96
Net Change in Cash-30.52-157.4%-220.91-143.90228.73-37.4%53.14-218.77-112.1%-238.69365.40+637.9%
Free Cash Flow327.63+11.0%188.21+77.2%67.86-25.2%393.86-13.0%295.07+15.0%106.22-55.9%90.78452.92+437.8%
Price to Free Cash Flow ratio5.676.027.608.598.176.794.656.95

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Bio supplies233.70173.70-25.7%2.0%
Haemoderivatives6,646.487,316.80+10.1%86.2%
Other Product225.05274.08+21.8%3.2%
Other diagnostic21.6419.17-11.4%0.2%
Transfusional medicine676.23702.69+3.9%8.3%
Total7,803.108,486.45+8.8%100.0%
Region
Name20242025vs 20242025 share
Country of domicile457.67471.47+3.0%5.6%
Other countries1,759.271,868.96+6.2%22.0%
Rest of European Union1,164.191,348.99+15.9%15.9%
United States and Canada4,421.974,797.03+8.5%56.5%
Total7,803.108,486.45+8.8%100.0%
Segment
Name20242025vs 20242025 share
All other segments225.05274.08+21.8%3.2%
Bio supplies233.70173.70-25.7%2.0%
Biopharma6,646.487,316.80+10.1%86.2%
Diagnostic697.86721.87+3.4%8.5%
Total7,803.108,486.45+8.8%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.32%6.0M258.1M534.88K
2026-10-152.71%7.0M258.1M572.65K
2026-09-302.71%7.0M258.1M627.51K
2026-09-151.32%3.4M258.1M599.98K
2026-08-311.32%3.4M258.1M635.59K
2026-08-141.36%3.5M258.1M667.33K
2026-07-311.34%3.5M258.1M701.05K
2026-07-152.46%6.3M258.1M690.72K
2026-06-302.37%6.1M258.1M665.96K
2026-06-152.33%6.0M258.1M692.45K
2026-05-292.28%5.9M258.1M732.38K
2026-05-152.31%6.0M258.1M759.06K
2026-04-302.19%5.7M258.1M745.69K
2026-04-152.09%5.4M258.1M664.84K
2026-03-312.04%5.3M258.2M649.35K
2026-03-132.72%7.0M258.2M571.22K
2026-02-272.75%7.1M258.2M538.12K
2026-02-132.51%6.5M257.4M491.64K
2026-01-302.67%6.9M257.3M587.38K
2026-01-152.68%6.9M257.3M601.11K

Option chain

Expiry 2026-11-20 · underlying 8.81, quoted 13 Nov 04:40 ET · ATM 9.00

Option quotes 5 Nov 15:40 ET. A date on a row is older than the last session (12 Nov). 32 rows.

Implied move 17.03% into expiry (call 0.625 + put 0.875 = 1.500 on 8.81)

Put/call open interest 0.56 (980 puts / 1,738 calls) · Put/call volume — no calls

IV change is points against the prior close.

TypeStrikeMoneyBidAskLastChgIVOpen intVolumeLast sizeDeltaThetaVega
call 1 Jan1.00ITM6.508.900.000.00-0000.991-0.0160.000
put 1 JanOTM0.000.050.000.00-000-0.009-0.0150.000
call 3 Nov2.00ITM5.607.906.600.001607.1% +881.50000.972-0.0370.001
put 1 JanOTM0.001.150.000.00725.7% 0.0000-0.027-0.0370.001
call 1 Jan3.00ITM4.706.900.000.001133.4% +596.80000.960-0.0370.001
put 1 JanOTM0.001.150.000.00536.6% 0.0000-0.039-0.0370.001
call 1 Jan4.00ITM3.705.900.000.00867.2% +459.30000.947-0.0360.001
put 1 JanOTM0.001.150.000.00408.0% 0.0000-0.053-0.0360.001
call 1 Jan5.00ITM2.604.900.000.00680.5% +371.20000.929-0.0340.002
put 1 JanOTM0.001.150.000.00309.4% 0.0000-0.070-0.0340.002
call 29 Jun6.00ITM1.704.001.850.00563.1% +335.20000.905-0.0310.002
put 27 AugOTM0.001.150.100.00228.0% 0.06700-0.094-0.0310.002
call 26 Oct7.00ITM1.202.050.990.00189.7% +33.050000.867-0.0280.003
put 14 OctOTM0.000.900.200.00154.6% 0.042800-0.134-0.0270.003
call 30 Oct8.00ITM0.051.500.400.00215.3% +120.0632000.774-0.0240.004
put 5 NovOTM0.001.200.240.0089.7% -5.648500-0.225-0.0230.004
call 2 Nov9.00ATM0.001.250.150.00266.4% -16.9708000.555-0.0910.005
put 1 JanATM0.001.750.000.00320.1% +36.5000-0.438-0.0920.005
call 25 Aug10.00OTM0.000.750.100.0087.2% 0.0347000.175-0.0190.003
put 9 AprITM0.152.552.280.00348.8% +261.6000-0.824-0.0180.003
call 24 Jul11.00OTM0.001.150.050.00126.0% 0.01000.132-0.0220.003
put 1 JanITM1.103.600.000.00412.5% +286.5000-0.867-0.0220.003
call 1 Jan12.00OTM0.001.150.000.00158.4% 0.00000.111-0.0250.002
put 1 JanITM2.104.600.000.00457.7% +299.4000-0.888-0.0240.002
call 1 Jan13.00OTM0.001.150.000.00186.5% 0.00000.098-0.0270.002
put 1 JanITM3.005.600.000.00496.8% +310.4000-0.901-0.0260.002
call 1 Jan14.00OTM0.001.150.000.00211.3% 0.00000.089-0.0280.002
put 1 JanITM4.006.600.000.00531.1% +319.8000-0.910-0.0270.002
call 1 Jan15.00OTM0.001.150.000.00233.7% 0.00000.083-0.0290.002
put 1 JanITM5.007.600.000.00561.8% +328.1000-0.916-0.0280.002
call 1 Jan16.00OTM0.001.150.000.00255.4% 0.00000.078-0.0300.002
put 1 JanITM6.008.600.000.00589.5% +335.5000-0.922-0.0290.002

Latest SEC filings

30 of 306
AllAll annual, quarterly, and current reportsInsider equity awards, transactions, and ownership (Section 16 Reports)Beneficial ownership reportsExempt offeringsRegistration statements and prospectusesFiling review correspondenceSEC orders and noticesProxy materialsTender offers and going private transactionsTrust indenture filings

10-Q was not on the first page of annual reports. 10-K was not on the first page of annual reports. GRFS on EDGAR

page 1 of 11Next →
FiledFormDescriptionPeriodDocument
2026-11-026-KAll annual, quarterly, and current reports2026-11-020001104659-26-121157 index
2026-11-026-KAll annual, quarterly, and current reports2026-11-020001104659-26-121154 index
2026-07-306-KAll annual, quarterly, and current reports2026-07-300001104659-26-088529 index
2026-07-296-KAll annual, quarterly, and current reports2026-07-280001104659-26-087634 index
2026-06-226-KAll annual, quarterly, and current reports2026-06-220001104659-26-076294 index
2026-06-186-KAll annual, quarterly, and current reports2026-06-180001104659-26-075705 index
2026-05-156-KAll annual, quarterly, and current reports2026-05-150001104659-26-062230 index
2026-05-14SCHEDULE 13G/ABeneficial ownership reportsno report period0001015079-26-000044 index
2026-05-076-KAll annual, quarterly, and current reports2026-05-070001104659-26-056966 index
2026-04-1720-FAll annual, quarterly, and current reports2025-12-310001104659-26-044901 index
2026-04-146-KAll annual, quarterly, and current reports2026-04-140001104659-26-043217 index
2026-03-246-KAll annual, quarterly, and current reports2026-03-240001104659-26-033917 index
2026-02-266-KAll annual, quarterly, and current reports2026-02-260001104659-26-020526 index
2026-02-266-KAll annual, quarterly, and current reports2026-02-260001104659-26-020407 index
2026-02-17SCHEDULE 13G/ABeneficial ownership reportsno report period0001472850-26-000003 index
2026-02-12SCHEDULE 13G/ABeneficial ownership reportsno report period0001015079-26-000022 index
2026-01-086-KAll annual, quarterly, and current reports2026-01-080001104659-26-002077 index
2025-12-166-KAll annual, quarterly, and current reports2025-12-160001104659-25-121424 index
2025-11-12SCHEDULE 13G/ABeneficial ownership reportsno report period0001015079-25-000014 index
2025-11-046-KAll annual, quarterly, and current reports2025-11-040001104659-25-106104 index
2025-09-296-KAll annual, quarterly, and current reports2025-09-290001104659-25-094131 index
2025-07-306-KAll annual, quarterly, and current reports2025-07-300001104659-25-071915 index
2025-07-296-KAll annual, quarterly, and current reports2025-07-290001104659-25-071644 index
2025-07-296-KAll annual, quarterly, and current reports2025-07-290001104659-25-071400 index
2025-06-126-KAll annual, quarterly, and current reports2025-06-110001104659-25-058641 index
2025-06-056-KAll annual, quarterly, and current reports2025-06-050001104659-25-056816 index
2025-05-126-KAll annual, quarterly, and current reports2025-05-120001104659-25-047168 index
2025-05-066-KAll annual, quarterly, and current reports2025-05-060001104659-25-044928 index
2025-05-026-KAll annual, quarterly, and current reports2025-05-020001104659-25-043975 index
2025-04-1120-FAll annual, quarterly, and current reports2024-12-310001104659-25-034245 index

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BRANDES INVESTMENT PARTNERS, LP14.64%
Capital World Investors8.87%
Permian Investment Partners, LP7.64%
BANK OF AMERICA CORP /DE/2.54%
Black Creek Investment Management Inc.2.48%
MILLENNIUM MANAGEMENT LLC1.69%
Flat Footed LLC1.68%
Jupiter Topco LLC1.15%
ARMISTICE CAPITAL, LLC1.14%
MORGAN STANLEY1.03%

Funds

Fund% owned
New Perspective Fund5.44%
International Growth and Income Fund2.01%
Brandes International Small Cap Equity Fund1.86%
Brandes Small Cap Value Fund0.64%
Brandes International ETF0.35%
Brandes U.S. Small-Mid Cap Value ETF0.13%
International Growth and Income Fund0.04%
Brandes Global Equity Fund0.04%
ActivePassive International Equity ETF0.01%
Enterprise Mergers and Acquisitions Fund0.00%

OakChart. GRFS. Cached 15 minutes. Terms

Some panels did not load: insider.